-

Susan G. Komen and Amgen to Help People Understand and Monitor Breast and Bone Health

Bone Complication Impacts 70% of People Living with Metastatic Breast Cancer

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, today unveiled a new integrated campaign, in partnership with Amgen, to educate the breast cancer community about the link between breast and bone health, providing useful information for women of all ages and stages of breast cancer.

“Breast cancer treatment can affect bone health, and it is one of main areas where breast cancers spread when they metastasize. Yet no matter your age, health or breast cancer diagnosis, your bone health may also be at risk,” said Paula Schneider, president and CEO of Susan G. Komen and a breast cancer survivor. “Women have long known that it is important to understand what is normal for their breast health and to talk to their doctor if they notice any changes. Women need to include their bones in this moment of vigilance.”

Metastatic breast cancer, also known as stage IV breast cancer, is when the breast cancer spreads beyond the breast and nearby lymph nodes to other parts of the body, often the bones. When breast cancer cells spread to the bones, lesions can occur that cause the bones to break easily and may result in spinal cord compression. Research shows that 70 percent of women with bone metastasis will have a skeletal related event within two years of diagnoses. All of these skeletal complications can lead to chronic pain and the loss of mobility.

Through a mixture of facts and personal storytelling, the integrated campaign will drive people to komen.org/breast-and-bone-health, where women will be provided useful information about their breast and bone health, including:

  • Questions to ask your doctor about metastatic breast cancer and bone protection
  • How to protect bones from fractures and other problems, including through diet
  • What treatments may negatively impact bone health
  • What drugs are available to improve bone density

Amgen also provides additional information for people living with metastatic breast cancer on its website – Let’s Talk Bone Mets.

Together, the two organizations seek to inspire people to learn more about their breast and bone health and become empowered to monitor their health and have constructive conversations with their health care teams.

About Susan G. Komen®

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit www.komen.org or call 1-877 GO KOMEN. Connect with us on social media at www.komen.org/contact-us/follow-us/.

Contacts

Sean Tuffnell
Susan G. Komen®
972-855-4382
press@komen.org

Susan G. Komen


Release Summary
Susan G. Komen and Amgen unveiled a new campaign to educate the breast cancer community about the link between breast and bone health.
Release Versions

Contacts

Sean Tuffnell
Susan G. Komen®
972-855-4382
press@komen.org

Social Media Profiles
More News From Susan G. Komen

Legislation Eliminates Financial Barriers to Critical Breast Imaging, Would Help Thousands Across Hawaii Afford Care They Require

HONOLULU--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization commends Representative Lauren Matsuomto (R-Mililani) introducing legislation to ensure equitable access to required diagnostic and supplemental breast imaging, by eliminating the financial barriers patients face in accessing needed breast cancer screening. The exorbitant out-of-pocket costs associated with this critical breast imaging, ranging from hundreds to thousands of dollars, often force individual...

Breast Cancer 2026 Progress Outlook: New Research Discoveries and Opportunities

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, today issued its 2026 Breast Cancer Progress Outlook. New data shows the U.S. breast cancer death rate has declined 44% between its peak in 1989 and 2023 — averting an estimated 546,000 deaths due largely to advances in treatment and earlier detection through screening. Yet breast cancer remains an urgent public health challenge. Incidence of invasive breast cancer has been rising since the mid-2000s, incr...

A Night to Remember: Susan G. Komen® and Trisha Yearwood Announce Star-Studded Lineup for The Second Annual "Band As One Nashville Concert for the Cure" at The Opry House

NASHVILLE, Tenn.--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, and country music icon Trisha Yearwood, today announced the confirmed line up for the second annual “Band As One Nashville Concert for the Cure: Trisha Yearwood & Friends” on March 22, 2026. This year’s event will celebrate those that have been impacted by breast cancer at a new location: The historic Opry House. Yearwood will return as the event headliner along with some of music’s most reco...
Back to Newsroom